Related Experiment Video
Updated: Jan 29, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Subclass-Aware Contrastive Semi-Supervised Learning for Inflammatory Bowel Disease Classification from Colonoscopy
Kechen Lin1,2, Guangcong Ruan1, Xiaoyang Zou2
1Department of Gastroenterology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
None:
Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). The accurate classification of IBD from colonoscopy images is critical for diagnosis and treatment. However, the lack of labeled data poses a major challenge for developing deep learning-based IBD classification approaches. Recently, pseudo-labeling-based semi-supervised learning methods offer a promising solution in leveraging both labeled and unlabeled data to improve classification performance. Nevertheless, due to significant intra-class variability and the subtle inter-class differences in IBD colonoscopy images, pseudo-labels are often inaccurate, which results in confirmation bias and suboptimal performance. To address this challenge, a Subclass-Aware Contrastive Semi-Supervised Learning method, referred to as SACSSL, is proposed for accurate IBD classification by integrating a subclass-aware contrastive module into a pseudo-labeling-based semi-supervised framework, e.g., FixMatch. Specifically, unlabeled samples are first partitioned into confident and uncertain samples according to the confidence of pseudo-labels. An instance-level contrastive loss is then applied to uncertain samples, aiming to mitigate confirmation bias. Furthermore, intra-class heterogeneity is captured by introducing a set of prototypes for each subclass and assigning confident samples to these prototypes to form fine-grained subclasses, and supervised contrastive loss is applied to promote intra-subclass clustering, thereby enhancing inter-class separability while preserving intra-class diversity. Our method is evaluated on two datasets, i.e., an in-house collected Daping dataset for IBD classification and a publicly available LIMUC dataset for UC severity grading. On both datasets, our method achieves state-of-the-art performance under the semi-supervised setting. Specifically, with only 20% labeled data, the proposed method reaches an overall accuracy of 93.2% and an F1-score of 80.1% on the Daping dataset, which is close to the fully supervised upper bound (94.0% accuracy and 80.8% F1-score), and it achieves an overall accuracy of 76.4% and an F1-score of 68.9% on the LIMUC dataset. Comprehensive experimental results demonstrate the effectiveness of our method for semi-supervised colonoscopy image classification.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Self-Awareness and Its Effects

